JP2009502113A - 乳癌を治療するための組成物および方法 - Google Patents

乳癌を治療するための組成物および方法 Download PDF

Info

Publication number
JP2009502113A
JP2009502113A JP2008503305A JP2008503305A JP2009502113A JP 2009502113 A JP2009502113 A JP 2009502113A JP 2008503305 A JP2008503305 A JP 2008503305A JP 2008503305 A JP2008503305 A JP 2008503305A JP 2009502113 A JP2009502113 A JP 2009502113A
Authority
JP
Japan
Prior art keywords
polypeptide
breast cancer
sequence
seq
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008503305A
Other languages
English (en)
Japanese (ja)
Inventor
祐輔 中村
豊雅 片桐
修一 中鶴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of JP2009502113A publication Critical patent/JP2009502113A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2008503305A 2005-07-25 2006-07-21 乳癌を治療するための組成物および方法 Pending JP2009502113A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70244605P 2005-07-25 2005-07-25
PCT/JP2006/314945 WO2007013574A1 (en) 2005-07-25 2006-07-21 Compositions and methods for treating breast cancer

Publications (1)

Publication Number Publication Date
JP2009502113A true JP2009502113A (ja) 2009-01-29

Family

ID=37025201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008503305A Pending JP2009502113A (ja) 2005-07-25 2006-07-21 乳癌を治療するための組成物および方法

Country Status (4)

Country Link
EP (1) EP1920056A1 (zh)
JP (1) JP2009502113A (zh)
CN (1) CN101273132A (zh)
WO (1) WO2007013574A1 (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011024428A1 (en) * 2009-08-24 2011-03-03 Oncotherapy Science, Inc. Breast cancer related gene c12orf32
WO2011096211A1 (en) * 2010-02-03 2011-08-11 Oncotherapy Science, Inc. Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
WO2011096210A1 (en) * 2010-02-03 2011-08-11 Oncotherapy Science, Inc. Prmt1 and prmt6 for target genes of cancer therapy and diagnosis
US8512944B2 (en) 2008-08-27 2013-08-20 Oncotherapy Science, Inc. PRMT1 for target genes of cancer therapy and diagnosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
WO2004078205A1 (en) * 2003-03-03 2004-09-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Targeting a protein prc1 for the treatment of pancreatic cancer

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512944B2 (en) 2008-08-27 2013-08-20 Oncotherapy Science, Inc. PRMT1 for target genes of cancer therapy and diagnosis
WO2011024428A1 (en) * 2009-08-24 2011-03-03 Oncotherapy Science, Inc. Breast cancer related gene c12orf32
WO2011096211A1 (en) * 2010-02-03 2011-08-11 Oncotherapy Science, Inc. Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
WO2011096210A1 (en) * 2010-02-03 2011-08-11 Oncotherapy Science, Inc. Prmt1 and prmt6 for target genes of cancer therapy and diagnosis

Also Published As

Publication number Publication date
CN101273132A (zh) 2008-09-24
EP1920056A1 (en) 2008-05-14
WO2007013574A1 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
JP5764822B2 (ja) がんの治療および診断の標的遺伝子としてのｐｒｍｔ１
WO2011096210A1 (en) Prmt1 and prmt6 for target genes of cancer therapy and diagnosis
US9062309B2 (en) Use of a growth-stimulating protein
JP5640263B2 (ja) Ｄｅｐｄｃ１ポリペプチドを使用した膀胱癌の治療または予防のための方法
WO2010095364A1 (en) Jarid1b for target gene of cancer therapy and diagnosis
JP2006500916A (ja) ｈｎＲＮＰＡ１およびＡ２核酸分子と関連がある新形成を治療するための方法および組成物
US20110251090A1 (en) Pancreatic cancer related gene ttll4
JP2009502113A (ja) 乳癌を治療するための組成物および方法
JP2010523081A (ja) Ｃｄｃａ８−ａｕｒｋｂ複合体を標的とするスクリーニング方法およびｎｓｃｌｃの治療方法
JP6064231B2 (ja) がん治療および診断のための標的遺伝子としてのｓｕｖ３９ｈ２
WO2010023855A1 (en) C12orf48 as a target gene for cancer therapy and diagnosis
KR20110063494A (ko) 암 치료 및 진단을 위한 표적 유전자인 ｏｉｐ５
JP2012501166A (ja) 乳癌関連遺伝子ｒｑｃｄ１
WO2012023259A1 (en) C6orf167 as a target gene for cancer therapy and diagnosis
WO2012023287A1 (en) Suv420h1 and suv420h2 as target genes for cancer therapy and diagnosis
JP2013502901A (ja) がんの治療および診断の標的遺伝子としてのｅｒｃｃ６ｌ